For general media inquiries, please contact mediainquiries@jenner.com.
News
Jenner & Block Secures Trial Victory for Chance the Rapper
News
Recognition
Jenner & Block Named Law Firm of the Year, Earned Additional Honors Across Categories by The American Lawyer 2025 Industry Awards
Recognition
Recognition
Chicago Bar Association Names Jenner & Block Law Firm of the Year
Recognition
All News and Insights
News
Last month, Partner Neil Barofsky testified before the US Senate Judiciary Committee to present findings from the ongoing investigation into Credit Suisse's historical ties to Nazi-era clients. His testimony, which included a 75-page written statement, revealed previously unreported relationships between the bank and Nazi-era entities.
Jenner & Block Files Federal Class Action Challenging Solitary Confinement of Youth in New York
Jenner & Block, in partnership with The Legal Aid Society, has filed a federal class action lawsuit challenging the New York State Office of Children and Family Services' (OCFS) practice of subjecting youth to solitary confinement.
Jenner & Block Team Secures Asylum for Afghanistan Refugees
A family from Afghanistan now has asylum in the United States thanks to the efforts of a Jenner & Block team.
Recognitions
Legal Aid Society Honors Jenner & Block Team with Pro Bono Publico Award
On December 16, The Legal Aid Society recognized a Jenner & Block team with a 2021 Pro Bono Publico award for “providing significant and invaluable support in litigation around the use of hotels for people who are homeless during the pandemic.”
Publications
US Supreme Court Rejects Heightened Standard for International Arbitration Award
On June 5, 2025, the US Supreme Court held, in a unanimous decision, that civil litigants in US courts seeking to enforce an arbitration award against foreign nations or instrumentalities do not need to meet a higher standard for jurisdiction than the one set forth by the Foreign Sovereign Immunities Act of 1976 (the “FSIA”). CC/Devas (Mauritius) Ltd. v. Antrix Corp., No. 23-1201. Though the Court’s opinion is fairly narrow and non-controversial, it suggests that future efforts by foreign nation
In an article for Pratt’s Cybersecurity Law Report, Partner Jacob Alderdice and Associates Billy Goldstein and Elizabeth Avunjian survey the thorny issues involving attorney-client privileged documents that can arise in disputes between buyers and sellers after a merger or acquisition has closed.
In an article for the American Bar Association, Partner Jacob Alderdice and Associate Billy Goldstein provide insight on the recurring risk of class action lawsuits faced by companies in the life sciences and other fields arising from disclosures about their interactions with the US Food and Drug Administration.
Client Alerts
The Future of Pharmaceutical Advertising on Television: Legal and Regulatory Considerations
The debate over pharmaceutical advertising on television has resurfaced with renewed vigor, among populist conservatives and activists, such as Charlie Kirk, who have advocated for regulatory intervention, and from Robert F. Kennedy Jr., the nominee for Secretary of HHS, and Brendan Carr, the new FCC Chairman, who have either called for or agreed with calls to ban pharmaceutical advertising. This article examines the potential for restrictions on direct-to-consumer (DTC) pharmaceutical advertisi
